| mitochondrion organization | GO:0007005 | 134 | 0.655 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.115 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.106 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.102 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.092 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.092 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.091 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.081 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.080 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.072 | |
| defecation | GO:0030421 | 1 | 0.071 | |
| transmembrane transport | GO:0055085 | 412 | 0.071 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.070 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.067 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.065 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.058 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.056 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.053 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.053 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.053 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.052 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.051 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.047 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.042 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.042 | |
| spermatogenesis | GO:0007283 | 284 | 0.041 | |
| translation | GO:0006412 | 93 | 0.040 | |
| response to oxidative stress | GO:0006979 | 123 | 0.039 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.039 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.037 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.035 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.032 | |
| oxidation reduction process | GO:0055114 | 342 | 0.031 | |
| multicellular organism growth | GO:0035264 | 161 | 0.031 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.029 | |
| male gamete generation | GO:0048232 | 285 | 0.029 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.029 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.028 | |
| response to oxygen levels | GO:0070482 | 62 | 0.028 | |
| striated muscle cell development | GO:0055002 | 125 | 0.028 | |
| intracellular protein transport | GO:0006886 | 204 | 0.028 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.027 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.027 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.027 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.027 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.026 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.026 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.026 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| amine metabolic process | GO:0009308 | 45 | 0.026 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.026 | |
| atp metabolic process | GO:0046034 | 75 | 0.026 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | |
| regulation of cell activation | GO:0050865 | 289 | 0.025 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.024 | |
| regulation of oxidative phosphorylation | GO:0002082 | 6 | 0.024 | |
| gland development | GO:0048732 | 330 | 0.023 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.023 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.023 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.022 | |
| cellular homeostasis | GO:0019725 | 240 | 0.022 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.021 | |
| immune effector process | GO:0002252 | 321 | 0.021 | |
| cation transport | GO:0006812 | 399 | 0.021 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.021 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.020 | |
| cristae formation | GO:0042407 | 3 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.020 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.020 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.020 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.020 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.020 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.019 | |
| iron sulfur cluster assembly | GO:0016226 | 3 | 0.019 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.019 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.019 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.019 | |
| cytokine production | GO:0001816 | 319 | 0.019 | |
| skin development | GO:0043588 | 220 | 0.019 | |
| protein localization to organelle | GO:0033365 | 185 | 0.019 | |
| germ cell development | GO:0007281 | 185 | 0.018 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.018 | |
| membrane organization | GO:0061024 | 245 | 0.018 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.018 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.018 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.018 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.018 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.018 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.018 | |
| muscle tissue development | GO:0060537 | 308 | 0.017 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.017 | |
| feeding behavior | GO:0007631 | 62 | 0.017 | |
| inflammatory response | GO:0006954 | 244 | 0.017 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.017 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.017 | |
| renal system development | GO:0072001 | 225 | 0.016 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.016 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.016 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.016 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.016 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.016 | |
| endocytosis | GO:0006897 | 168 | 0.016 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.016 | |
| t cell activation | GO:0042110 | 289 | 0.016 | |
| cellular respiration | GO:0045333 | 38 | 0.015 | |
| protein targeting | GO:0006605 | 143 | 0.015 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.015 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.015 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.015 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.015 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.015 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.015 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.015 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.015 | |
| mitochondrial translation | GO:0032543 | 4 | 0.015 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.014 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.014 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.014 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 38 | 0.014 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.014 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.014 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.014 | |
| response to hypoxia | GO:0001666 | 58 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.014 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.014 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.014 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.013 | |
| locomotory behavior | GO:0007626 | 195 | 0.013 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.013 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.013 | |
| action potential | GO:0001508 | 78 | 0.013 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.013 | |
| sensory perception | GO:0007600 | 245 | 0.013 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.013 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.013 | |
| muscle cell development | GO:0055001 | 133 | 0.013 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.013 | |
| regulation of defense response | GO:0031347 | 233 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.013 | |
| negative regulation of mammary gland epithelial cell proliferation | GO:0033600 | 3 | 0.013 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.013 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.013 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.012 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.012 | |
| digestive system development | GO:0055123 | 200 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| cardiac chamber development | GO:0003205 | 108 | 0.012 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.012 | |
| response to inorganic substance | GO:0010035 | 96 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| coenzyme a biosynthetic process | GO:0015937 | 5 | 0.012 | |
| mitochondrion morphogenesis | GO:0070584 | 13 | 0.012 | |
| neuron death | GO:0070997 | 154 | 0.012 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.012 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.012 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.012 | |
| protein localization to membrane | GO:0072657 | 108 | 0.011 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.011 | |
| neuronal action potential | GO:0019228 | 54 | 0.011 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.011 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.011 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.011 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.011 | |
| gtp metabolic process | GO:0046039 | 144 | 0.011 | |
| regulation of protein localization | GO:0032880 | 231 | 0.011 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.011 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.011 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.011 | |
| mitochondrial dna replication | GO:0006264 | 7 | 0.011 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.011 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.011 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.011 | |
| t cell differentiation | GO:0030217 | 174 | 0.011 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.011 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.011 | |
| pigment biosynthetic process | GO:0046148 | 26 | 0.011 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.011 | |
| oxidative phosphorylation | GO:0006119 | 14 | 0.011 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.011 | |
| t cell proliferation | GO:0042098 | 120 | 0.010 | |
| regulation of ion transport | GO:0043269 | 215 | 0.010 | |
| regulation of neuron death | GO:1901214 | 134 | 0.010 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.010 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.010 | |
| muscle fiber development | GO:0048747 | 76 | 0.010 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.010 | |
| positive regulation of growth | GO:0045927 | 104 | 0.010 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.010 | |
